Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ PubMed Centralarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
PubMed Central
Article . 2026
Data sources: PubMed Central
versions View all 2 versions
addClaim

Proton-based stereotactic radiosurgery and stereotactic body radiation therapy.

Authors: Xu, Zhengzheng; Woods, Kaley; Ma, Lijun; Chang, Eric;

Proton-based stereotactic radiosurgery and stereotactic body radiation therapy.

Abstract

Proton beam radiation has a unique depth-dose distribution with lower surface dose, peaked energy loss at the end of the traveling range, and negligible exit dose compared to photon radiation that allows better sparing of normal tissues and potential dose escalation to the tumor. With advanced proton beam delivery and imaging guidance systems and years of successful proton treatment experience, clinicians are moving forward to implement proton beam in stereotactic body radiation therapy (SBRT). Major challenges in implementing stereotactic body proton therapy (SBPT) still exist such as the proton range uncertainty, radiobiological modeling, and inter-fractional motion management. Recent studies have demonstrated the safety and efficacy of utilizing SBPT in treating central nervous system (CNS), lung, and liver tumors. However, more clinical trials involving large patient cohorts are needed to evaluate the long-term clinical outcomes of SBPT. In addition to the technical challenges, consensus guidelines on treating selected patients with SBPT are needed to ensure treatment quality. Lastly, more effort on SBPT insurance approval is needed to further expand its clinical application. This study introduces the fundamental and new technologies utilized in SBPT and summarizes the current status of SBPT implementation in treating CNS, lung, and liver tumors.

Related Organizations
Keywords

Clinical Investigation

  • BIP!
    Impact byBIP!
    citations
    The total number of citations received by all articles of the researcher of interest.
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
citations
The total number of citations received by all articles of the researcher of interest.
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average